Dariohealth chosen by northeast regional employer

Dario continues to expand its employer contracts across broad range of solutions new york, sept. 9, 2021 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a northeast regional employer ("employer").
DRIO Ratings Summary
DRIO Quant Ranking